Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$57.195
*  
0.175
0.31%
Get TEVA Alerts
*Delayed - data as of Mar. 2, 2015 10:57 ET  -  Find a broker to begin trading TEVA now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    TEVA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Supreme Court Sides With Teva in Patent Case on Copaxone -- 2nd Update
1/20/2015 4:57:00 PM - Dow Jones Business News


Update: Will Teva Lose Patent Protection For Copaxone After All?
1/20/2015 3:15:00 PM - Seeking Alpha


Supreme Court Sides With Teva in Patent Case on Copaxone -- Update
1/20/2015 12:44:00 PM - Dow Jones Business News


Supreme Court Sides With Teva in Patent Case on Copaxone
1/20/2015 10:46:00 AM - Dow Jones Business News


Teva Pharmaceutical Industries (TEVA) Has Spiked To The Upside
1/20/2015 10:13:00 AM - RTT News


OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog
1/19/2015 4:10:00 AM - Investopedia


Teva Pharma To Present At J.P. Morgan Healthcare Conference; Webcast At 6:30 PM
1/13/2015 3:00:00 PM - RTT News


Generics Prices Spike: 2 Stock Choices - Analyst Blog
1/12/2015 2:46:00 PM - Investopedia


Week In Review: WuXi PharmaTech Pays $65 Million For Genomics Company
1/11/2015 11:10:00 AM - Seeking Alpha


Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog
1/9/2015 4:39:00 AM - Investopedia


Xenon Pharma Anticipates Several Milestones In Partnered Programs
1/8/2015 8:32:00 AM - RTT News


Teva: New Generic Launches Will Benefit Earnings
1/7/2015 10:41:00 AM - Seeking Alpha


Update: U.S. Launch Of Generic Diovan Improves Teva's Outlook
1/7/2015 12:51:00 AM - Seeking Alpha


Teva Pharma. To Present At Goldman Sachs Conference; Webcast At 10:15 AM ET
1/6/2015 9:17:00 AM - RTT News


Canada Producer Prices Drop 0.4% in November
1/6/2015 9:16:00 AM - Dow Jones Business News


Teva Pharmaceutical To Participate In Goldman Sachs Conference At 10:15 AM ET
1/6/2015 6:06:00 AM - RTT News


Seeking Alpha's Biotech Weekly: 2014's Approval-Palooza, Ebola In Scotland, And More
1/2/2015 4:00:00 PM - Seeking Alpha


Teva Pharmaceutical Industries: Is It Time To Buy Or Sell?
1/1/2015 3:27:00 AM - Seeking Alpha


OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog
12/31/2014 2:55:00 PM - Investopedia


Pfizer Faces An Enormous Patent Cliff: Here Is How To Invest
12/31/2014 1:04:00 PM - Seeking Alpha


Epirus Biopharma: A High Risk/High Reward Biosimilar Investment
12/31/2014 6:59:00 AM - Seeking Alpha


OncoGenex Pharma To Regain Rights To Custirsen From Teva Pharmaceutical
12/30/2014 8:11:00 AM - RTT News


OncoGenex To Regain Rights To Custirsen From Teva - Quick Facts
12/30/2014 7:09:00 AM - RTT News


Teva's Granix Label Expanded to Include Self-Administration - Analyst Blog
12/30/2014 5:25:00 AM - Investopedia


Kang's Dividend Compounding Portfolio: 2014 Review
12/29/2014 4:15:00 AM - Seeking Alpha